Facebook’s Crypto Wallet ‘Calibra’ is Coming to WhatsApp in 2020

Joseph Young

Updated Tue, Jun 18, 2019, 6:51 AM

By CCN Markets: The whitepaper of Libra, a crypto asset created by a non-profit organization in Libra Association led by Facebook has been formally released, disclosing key details of the digital asset and the blockchain protocol that supports it.

As speculated, Libra will operate as a stablecoin backed by the Libra Reserve and will represent the value of existing assets such as reserve currencies.

Early preview of Calibra crypto wallet | Source: Facebook Newsroom

Facebook officially announced that Calibra, the first product built on top of Libra, will come to Messenger and WhatsApp as early as 2020, enabling users to send, receive, and store the crypto asset.

Following the footsteps of samsung in creating a crypto wallet

In its whitepaper, Libra Association clearly indicated that it aims to decentralize the Libra blockchain network and evolve it into a proper cryptocurrency.

Read the full story on CCN.com.

Morgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ Stocks
Uncertainty is the word of the day, in reference to the near-term economic future. Sentiment will hinge on the inflation numbers due out next week. March’s figure rose to 3.5%, and April’s job numbers showed a marked slowing in the labor market; that combination has stoked fears of stagflation. But – corporate earnings from Q1 are beating expectations, and the stock market has taken a turn for the better with the S&P 500 closing just below 5,200 yesterday. Economic strategists are still optimist
TipRanks
Billionaire Bill Gates Has 51% of His Portfolio Invested in 2 Brilliant Stocks
The Bill and Melinda Gates Foundation Trust outperformed the S&P 500 by a wide margin over the past three years, in part because of these two stocks.
Motley Fool
Can I Use My RMDs to Transfer Money Into My Roth IRA?
If you're taking a required minimum distribution from an IRA, 401(k) or other tax-deferred account and don't need the money to cover living expenses, where should you stash that unneeded cash? Investors now need to start taking RMDs at age 73 or, if they were born after 1960, at age 75. Depending on the balances of […] The post Can I Use My RMDs to Transfer Money Into My Roth IRA? appeared first on SmartReads by SmartAsset.
SmartAsset
Here's Exactly When Social Security Recipients Can Expect Benefit Cuts, According to the Latest Trustees Report
Social Security payments may be subject to cuts. Here's what the timing looks like.
Motley Fool
Time to Pounce: 2 Historically Cheap Ultra-High-Yield Energy Stocks That Are Begging to Be Bought Right Now
These supercharged energy income stocks -- with an average yield of 9.87% -- can really fatten your pocketbook.
Motley Fool
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts
High-water price targets from a trio of Wall Street pundits imply three diminutive companies can skyrocket 223% to 557%.
Motley Fool
3 Ridiculously Undervalued Stocks to Buy Hand Over Fist Right Now in May
Investing in cheap stocks brings unique risks because there is usually a reason the companies are undervalued.
Motley Fool
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business. Most Read from BloombergMicrosoft’s Xbox Is Planning More Cuts After Studio ClosingsAmericans Are Racking Up ‘Phantom Debt’ That Wall Street Can’t TrackStormy Daniels Will Return to Court in Test of Trump’s
Bloomberg
Stocks could tank after an ill-advised 'melt-up' if the Fed cuts rates to avoid recession
"Investors' expectation that the Fed would nip a recession in the bud by easing means that the Fed Put is back," Ed Yardeni said.
Business Insider
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Facebook’s Crypto Wallet ‘Calibra’ is Coming to WhatsApp in 2020

Following the footsteps of samsung in creating a crypto wallet

Recommended Stories

Morgan Stanley Predicts up to 110% Rally for These 2 ‘Strong Buy’ Stocks

Billionaire Bill Gates Has 51% of His Portfolio Invested in 2 Brilliant Stocks

Can I Use My RMDs to Transfer Money Into My Roth IRA?

Here's Exactly When Social Security Recipients Can Expect Benefit Cuts, According to the Latest Trustees Report

Time to Pounce: 2 Historically Cheap Ultra-High-Yield Energy Stocks That Are Begging to Be Bought Right Now

Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street Analysts

3 Ridiculously Undervalued Stocks to Buy Hand Over Fist Right Now in May

Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot

Stocks could tank after an ill-advised 'melt-up' if the Fed cuts rates to avoid recession

CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates